breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiske midler - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
levetiracetam "aristo pharma" 100 mg/ml oral opløsning
aristo pharma gmbh - levetiracetam - oral opløsning - 100 mg/ml
pantoprazol "oresund pharma" 40 mg pulver til injektionsvæske, opløsning
Øresund pharma aps - pantoprazolnatriumsesquihydrat - pulver til injektionsvæske, opløsning - 40 mg
natriumfusidat "essential pharma (m)" 500 mg pulver og solvens til koncentrat til infusionsvæske, opløsning
essential pharma (m) limited - fusidinsyre - pulver og solvens til koncentrat til infusionsvæske, opløsning - 500 mg
fingolimod "pharmathen" 0,5 mg kapsler, hårde
pharmathen s.a. - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
dimethylfumarat "pharmathen" 120 mg enterokapsler, hårde
pharmathen s.a. - dimethylfumarat - enterokapsler, hårde - 120 mg
kaliumklorid "eql pharma" 750 mg depottabletter
eql pharma ab - kaliumchlorid - depottabletter - 750 mg
ondansetron "pharmathen" 2 mg/ml injektions-/infusionsvæske, opløsning
pharmathen s.a. - ondansetronhydrochloriddihydrat - injektions-/infusionsvæske, opløsning - 2 mg/ml
epiduo 1 mg/g+25 mg/g gel
nordic prime aps - adapalen, benzoylperoxid, vandig - gel - 1 mg/g+25 mg/g
duovent 1,25+0,5 mg/beholder inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder
orifarm a/s - fenoterolhydrobromid, ipratropiumbromid - inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder - 1,25+0,5 mg/beholder